All In Against Cancer

Gastric (stomach) and esophageal cancers are common malignancies that affect the first parts of the digestive tract. About 50,000 new cases of gastric and esophageal cancer will be diagnosed each year in the United States. In this episode of the All In Against Cancer podcast, gastrointestinal medical oncologist Dr. Jonathan Mizrahi talks with Ochsner surgical oncologist, Dr. Nathan Bolton, and surgical oncology nurse practitioner, Jessica Pride, to learn more about the diagnosis, staging and management of patients with gastroesophageal cancers.

Bladder cancer is one of the most common cancer diagnoses in the United States.  In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Brian Halbert, and Ochsner urologist, Dr. Ro Arcot, about bladder cancer.  Tune in to hear more about the approach to diagnosis, staging, treatment and prevention of bladder cancer.

Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer.  More than 260,000 diagnoses of breast cancer are made each year in this country. Advances in screening techniques and identifying who may be at higher risk for the development of breast cancer has allowed us to provide more targeted screening recommendations for our patients.  In this episode of the All In Against Cancer podcast, we talk with Ochsner breast oncology nurse practitioners Erica Doubleday and Peggy Jo Alker to learn more the importance of and services provided by Ochsner's high risk breast cancer clinic.

Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer.  More than 260,000 diagnoses of breast cancer are made each year in this country, and the majority of these are found at an early enough stage that surgery is a preferred option.    In this episode of the All In Against Cancer podcast, we talk with Ochsner breast surgeon, Dr. Alexa Elder, and plastic surgeon, Dr. Christopher Smith, to learn more about the different types of breast cancer surgeries and how surgical decisions are made in collaboration with patients.

Neuroendocrine tumors represent an uncommon type of cancer that is best managed with a multidisciplinary approach by experts in this disease.  There is a wide range of tumor aggressiveness, prognosis, and potential treatment options which largely depends on how the cancer cells appear under the microscope.   In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Andrew Marsala, about neuroendocrine tumors.  Both Dr. Du and Dr. Marsala specialize in the management of neuroendocrine tumors and are members of the Ochsner Neuroendocrine Tumor Team. Tune in to hear more about the approach to diagnosis and treatment of neuroendocrine tumors.

Liver cancer is one of the most common types of cancer worldwide and represents the third most common cause of cancer-related death globally. About 75% of liver cancers arise from the liver cells – and these cancers are called hepatocellular carcinoma, or HCC.  The majority of the remaining liver cancers arise from the bile ducts that traverse the liver- and these cancers are referred to biliary tract cancers, or cholangiocarcinoma. In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Tyler Sandow, about liver cancer. Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for liver cancer.

Prostate cancer is the second most common cancer in males in the United States with almost a quarter of a million men diagnosed each year.  Advances in surgical and radiation techniques have improved the treatment landscape for patients with localized disease, and novel therapies have allowed us to make headway in our management of those with advanced prostate cancer.  In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Zoe Larned, and Ochsner urologist, Dr. Sean Collins, about prostate cancer. Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for prostate cancer.

Leukemia is one of the most common cancers with over 60,000 new patients receiving this diagnosis each year in the United States.  While leukemia refers to a malignancy of white blood cells, it is an umbrella term for a number of subtypes that carry their own prognoses and treatments. In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner hematologic oncologists, Dr. Carter Davis and Dr. Laura Finn about leukemia. Tune in to hear more about the signs and symptoms and our approach to the diagnosis and  treatment of this cancer.

Clinical trials represent the fundamental agents of progress in cancer care.  They allow us to move the needle in advancing new therapies and evaluating novel treatment approaches for our patients.  Tens of thousands of cancer patients enroll in clinical trials each year across the United States. In this special episode of the All In Against Cancer podcast, join host Dr. Jon Mizrahi in a discussion with with Ochsner medical oncologist, Dr. Marc Matrana, and oncology nurse practitioner, Erin Pierce, to learn more about the role and types of clinical trials in oncology and discuss the unique clinical trial opportunities at Ochsner.  We will also clear up some common misconceptions about trials and touch upon what we envision for the future of clinical research.

Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer.  Although more than 260,000 diagnoses of breast cancer are made each year in this country, advances in screening and therapies for this disease have led to continued declines in mortality. In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Melanie Sheen, and Ochsner breast surgical oncologist, Dr. Amy Rivere, about breast cancer. Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for breast cancer.

In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner radiation oncologist, Dr. Jeff Burkeen, and Ochsner colorectal surgeon, Dr. Forrest Johnston, about colorectal cancer. Colorectal cancer is one of the most common cancers in the United States.  While improvements in screening and early detection have been made, this disease still accounts for over 50,000 deaths in this country per year.  Advances in systemic, radiation and surgical therapies have improved outcomes for patients with colorectal cancer, and increasingly, oncologists are able to tailor treatments to target individual tumor vulnerabilities.   Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for colorectal cancer.

In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Suma Satti, and Ochsner thoracic surgeon, Dr. Brian Pettiford, about lung cancer.  Lung cancer is the second most common cancer in the United States, but is by far the most common cause of cancer death.   Help end the stigma around the diagnosis of lung cancer, and join us in promoting screening for high-risk populations.  Hear about how treatment options have advanced considerably for patients with all stages of this cancer.  Learn more about the diagnosis, treatment and prevention of lung cancer from experts at the Ochsner Cancer Institute by listening to our educational conversation.  

More than 100,000 people in the United States are expected to be diagnosed with melanoma in 2021.  Melanoma is a cancer that affects adults both young and old, and its incidence is unfortunately on the rise.  In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Daniel Johnson, and Ochsner dermatologist, Dr. Julie Danna, to learn more about the signs and symptoms of melanoma, what treatment options are available to patients and how to reduce risk for developing this disease.

According to the American Cancer Society, about 60,000 people in the United States will be diagnosed with pancreatic cancer this year. In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner surgical oncologist, Dr. Nathan Bolton, to learn more about the signs and symptoms of pancreatic cancer, what treatment options are available to patients and how to reduce risk for pancreatic cancer.